Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway

Detalles Bibliográficos
Autores principales: Song, Jie, Zhao, Wei, Lu, Chang, Shao, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936120/
https://www.ncbi.nlm.nih.gov/pubmed/31892858
http://dx.doi.org/10.1186/s12935-019-1084-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936120/
https://www.ncbi.nlm.nih.gov/pubmed/31892858
http://dx.doi.org/10.1186/s12935-019-1084-7

Ejemplares similares